Search
Fostemsavir
go.drugbank.com/drugs/DB11796ApprovedInvestigationalFostemsavir is the phosphonooxymethyl prodrug of temsavir, a novel HIV-1 attachment inhibitor. … [L14867] The discovery of gp120 as a potential target of interest in the treatment of HIV-1 infection is relatively recent, and was born out of a desire to find alternative target proteins (i.e. mechanistically
Maftivimab
go.drugbank.com/drugs/DB15899ApprovedInvestigationalINMAZEB™ is produced by Regeneron Pharmaceuticals and was granted FDA approval on October 14, 2020.[L17320] … [A221825, A221830] A recent large-scale study elucidated that both neutralizing and Fc-mediated functions of antibodies were important for therapeutic benefit in animal models of EBOV infection.
Piracetam
go.drugbank.com/drugs/DB09210ApprovedWithdrawnIt is not approved for any medical or dietary use by the FDA. … Piracetam is a nootropic drug in the racetams group, with chemical name 2-oxo-1-pyrrolidine acetamide.
Categories: Compounds used in a research, industrial, or household settingTegaserod
go.drugbank.com/drugs/DB01079ApprovedWithdrawnlower risk of a cardiovascular event than the broader population. … Novartis' brand name Zelnorm (tegaserod) had originally received approval from the US FDA in 2002 for the treatment of irritable bowel syndrome with constipation (IBS-C).
Navarixin
go.drugbank.com/drugs/DB11711InvestigationalNavarixin has been investigated for the treatment of Asthma.
Categories: Receptors, Interleukin-8A, antagonists & inhibitorsChlorambucil
go.drugbank.com/drugs/DB00291ApprovedInvestigationalA nitrogen mustard alkylating agent used as antineoplastic agent for the treatment of various malignant and nonmalignant diseases. … Although it is less toxic than most other nitrogen mustards, it has been listed as a known carcinogen in the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (Merck Index, 11th ed)
Synonyms: γ-[p-di(2-chloroethyl)aminophenyl]butyric acid, N,N-di-2-chloroethyl-γ-p-aminophenylbutyric acidBenidipine
go.drugbank.com/drugs/DB09231InvestigationalIt is a synthetic dihydropyridine derivative that has anti-hypertensive and anti-anginal actions. … [A31948] It was originated in Japan by Kyowa Hakko, it is submitted for FDA approval and it is currently available in some Asian countries like India and Japan.[L1385, L1386]
Darexaban
go.drugbank.com/drugs/DB12289InvestigationalDarexaban has been used in trials studying the prevention and basic science of Japanese, Caucasian, Thromboembolism, Pharmacodynamics, and Pharmacokinetics, among others.
Categories: Factor Xa Inhibitors